Biophytis S.A. (BPTSY)
USD 3.05
(0.0%)
USD 3.05
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -50.16 Thousand EUR | 76.65% |
| 2022 | -59.32 EUR | 50.55% |
| 2021 | -119.95 EUR | 42.3% |
| 2020 | -207.90 EUR | 58.71% |
| 2019 | -503.51 USD | -5.07% |
| 2018 | -479.23 USD | 19.57% |
| 2017 | -595.86 USD | -10.37% |
| 2016 | -539.87 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.90 USD | 67.7% |
| 2024 Q2 | -0.00 USD | 0.0% |
| 2023 Q4 | -2.70 USD | -4.65% |
| 2023 FY | - EUR | 77.36% |
| 2023 Q1 | -5.14 USD | 59.01% |
| 2023 Q3 | -2.58 USD | 50.1% |
| 2023 Q2 | -5.17 USD | -0.58% |
| 2022 FY | - EUR | 47.43% |
| 2022 Q2 | -17.58 USD | 0.0% |
| 2022 Q4 | -12.54 USD | 0.0% |
| 2021 Q2 | -28.38 USD | 0.0% |
| 2021 Q4 | -32.40 USD | 0.0% |
| 2021 FY | - EUR | 38.08% |
| 2020 FY | - EUR | 63.92% |
| 2020 Q4 | -34.90 USD | 0.0% |
| 2020 Q2 | -82.74 USD | 0.0% |
| 2019 Q4 | -96.21 USD | 0.0% |
| 2019 FY | - USD | 4.42% |
| 2018 FY | - USD | 11.91% |
| 2017 FY | - USD | 1.27% |
| 2016 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -50.78 USD | -98682.631% |
| Nanobac Pharmaceuticals, Incorporated | - USD | Infinity% |
| SQZ Biotechnologies Company | -2.76 USD | -1817357.246% |
| Evofem Biosciences, Inc. | 10.35 USD | 484755.266% |
| Santhera Pharmaceuticals Holding AG | 5.95 USD | 843155.798% |
| Mesoblast Limited | -0.09 USD | -56298238.945% |
| Propanc Biopharma, Inc. | -0.02 USD | -211653148.945% |
| Genus plc | 0.12 USD | 41801616.667% |
| VioQuest Pharmaceuticals, Inc. | -2.33 USD | -2152767.811% |
| CNBX Pharmaceuticals Inc. | -0.42 USD | -11943190.476% |
| Marizyme, Inc. | -1.44 USD | -3483359.722% |
| ContraFect Corporation | -124.97 USD | -40039.089% |
| Nymox Pharmaceutical Corporation | -0.10 USD | -51981060.622% |
| PsyBio Therapeutics Corp. | -0.04 USD | -119432804.762% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -0.01 USD | -418015066.667% |
| Intellipharmaceutics International Inc. | -0.09 USD | -57393286.728% |
| AXIM Biotechnologies, Inc. | -0.04 USD | -141699956.497% |
| MultiCell Technologies, Inc. | -0.00 USD | -50161819900.0% |
| Accustem Sciences Inc. | -0.34 USD | -14753376.471% |
| RVL Pharmaceuticals plc | -0.58 USD | -8648489.655% |
| EV Biologics, Inc. | -0.12 USD | -41801416.667% |
| Q BioMed Inc. | -0.08 USD | -64227582.458% |
| Emmaus Life Sciences, Inc. | -0.07 USD | -71353840.256% |
| Neon Bloom, Inc. | -0.00 USD | -3344121233.333% |
| Mosaic ImmunoEngineering Inc. | -0.33 USD | -15200451.515% |
| Biomind Labs Inc. | -0.02 USD | -309640764.198% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -0.02 USD | -311563999.379% |
| Oncotelic Therapeutics, Inc. | -0.02 USD | -252069347.236% |
| Skye Bioscience, Inc. | -5.37 USD | -934012.104% |
| Therapeutic Solutions International, Inc. | -0.00 USD | -7165974185.714% |
| THC Farmaceuticals, Inc. | -0.00 USD | -6270227400.0% |
| Arch Therapeutics, Inc. | -2.27 USD | -2209671.806% |
| IMV Inc. | -4.37 USD | -1147767.735% |
| Acro Biomedical Co., Ltd. | -0.26 USD | -19292907.692% |
| Curative Biotechnology, Inc. | -0.01 USD | -570020581.818% |
| GB Sciences, Inc. | -0.00 USD | -1223458924.39% |
| Alpha Cognition Inc. | -0.15 USD | -33441113.333% |
| HST Global, Inc. | -0.03 USD | -179791369.534% |
| CSL Limited | 2.73 USD | 1837529.304% |
| Halberd Corporation | -0.00 USD | -50161819900.0% |
| Enzolytics Inc. | -0.00 USD | -7165974185.714% |
| Resverlogix Corp. | -0.01 USD | -353252153.521% |
| Affymax, Inc. | -0.39 USD | -12861905.128% |
| SYBLEU INC | -0.02 USD | -286638871.429% |
| Nuo Therapeutics, Inc. | -0.08 USD | -66527512.732% |
| argenx SE | -5.16 USD | -972028.295% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -0.06 USD | -87237847.826% |
| Enzon Pharmaceuticals, Inc. | 0.00 USD | 3858601638.462% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -0.04 USD | -140509199.72% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -0.02 USD | -250809000.0% |
| AVAX Technologies, Inc. | -0.05 USD | -93064501.113% |
| Zenith Capital Corp. | -0.07 USD | -71762160.372% |
| Genscript Biotech Corporation | -0.05 USD | -110488490.308% |
| Ember Therapeutics, Inc. | -0.01 USD | -796219265.079% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -3.77 USD | -1330452.255% |
| WPD Pharmaceuticals Inc. | -0.00 USD | -10032363900.0% |
| American Oriental Bioengineering, Inc. | -781.24 USD | -6320.795% |
| Provectus Biopharmaceuticals, Inc. | -0.01 USD | -677862332.432% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -4.70 USD | -1067172.766% |
| GlobeStar Therapeutics Corporation | -0.00 USD | -2090075733.333% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -36.39 USD | -137745.067% |
| Cotinga Pharmaceuticals Inc. | -0.09 USD | -54941652.464% |
| BioStem Technologies, Inc. | -0.62 USD | -8090516.129% |
| ONE Bio Corp. | 1.43 USD | 3507919.58% |
| Reve Technologies, Inc. | -0.01 USD | -421527799.16% |
| Burzynski Research Institute, Inc. | -0.01 USD | -491782449.02% |
| Wesana Health Holdings Inc. | -0.05 USD | -100123293.214% |
| Agentix Corp. | -0.04 USD | -143319385.714% |
| LadRx Corporation | 0.68 USD | 7376838.235% |
| Cell Source, Inc. | -0.17 USD | -29506852.941% |
| ProtoKinetix, Incorporated | -0.01 USD | -501618100.0% |
| Regen BioPharma, Inc. | 0.29 USD | 17297279.31% |
| Regen BioPharma, Inc. | 0.26 USD | 19293107.692% |
| NovAccess Global Inc. | -0.23 USD | -21809386.957% |
| Endonovo Therapeutics, Inc. | 0.03 USD | 199847988.446% |
| Itoco Inc. | -0.01 USD | -660023847.368% |
| Rasna Therapeutics, Inc. | -0.01 USD | -501618100.0% |
| Pathfinder Cell Therapy, Inc. | -0.00 USD | -2006472700.0% |
| Kadimastem Ltd | -0.78 USD | -6430902.564% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -0.05 USD | -97401492.233% |
| CytoDyn Inc. | -0.05 USD | -94823756.333% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -0.00 USD | -10032363900.0% |
| Mobile Lads Corp. | -0.01 USD | -895746685.714% |
| NanoSphere Health Sciences Inc. | -0.02 USD | -225954044.144% |
| Qrons Inc. | -0.06 USD | -86040757.633% |
| Alseres Pharmaceuticals, Inc. | -153.67 USD | -32542.559% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -0.01 USD | -374341840.299% |
| Rebus Holdings, Inc. | -0.03 USD | -156267252.025% |
| ImmunoCellular Therapeutics, Ltd. | -0.01 USD | -353252153.521% |
| International Stem Cell Corporation | -0.02 USD | -305864656.098% |
| Bioxytran, Inc. | -0.03 USD | -157246984.639% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -0.00 USD | -50161819900.0% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -7.99 USD | -627707.509% |
| Adhera Therapeutics, Inc. | -1.18 USD | -4250901.695% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -0.03 USD | -147534664.706% |
| Innovation Pharmaceuticals Inc. | -0.01 USD | -796219265.079% |
| Neutra Corp. | -0.00 USD | -50161819900.0% |
| Windtree Therapeutics, Inc. | -94.23 USD | -53133.386% |
| PureTech Health plc | -2.38 USD | -2107539.496% |
| Coeptis Therapeutics, Inc. | -0.83 USD | -6043492.771% |
| IXICO plc | -0.02 USD | -205581129.508% |
| IntelGenx Technologies Corp. | -0.06 USD | -88312963.38% |
| Gelesis Holdings, Inc. | -1.35 USD | -3715590.37% |
| CSL Limited | 5.47 USD | 917135.101% |
| Cellectis S.A. | -1.77 USD | -2833901.13% |